Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models

Sarah M. Carpanini(UK Dementia Research Institute), B. Paul Morgan(UK Dementia Research Institute)
Acta Neuropathologica Communications
July 6, 2022
10.1186/s40478-022-01404-w
Cited by 97

Related Papers

Inflammatory biomarkers in Alzheimer's disease plasma
|Alzheimer s & Dementia|2019|207
Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis
|Journal of Clinical Investigation|2011|129
The complement system in neurodegenerative diseases
|Clinical Science|2024|48
Complement receptor 1 is expressed on brain cells and in the human brain
|Glia|2023|34
Brain-penetrant complement inhibition mitigates neurodegeneration in an Alzheimer’s disease mouse model
|Brain|2024|18